Clinical trial
Expression and Clinical Significance of PD-L1 and BRAF Expression in Nasopharyngeal Carcinoma
NCT03989297 is registered in ClinicalTrials.gov with Kiang Wu Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Expression and Clinical Significance of PD-L1 and BRAF Expression in Nasopharyngeal Carcinoma
- Lead sponsor
- Kiang Wu Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2017
- Completion date
- December 30, 2019
- Enrollment
- 104 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.